| BRC No. | Strain name | Strain type | Research application |
|---|---|---|---|
| RBRC03510 | B6.Cg-Tg(Fabp4-Foxo1*d256)/Rbrc | Transgene | |
| RBRC03545 | Alternative IL-15 Tg (B6) | Transgene | |
| RBRC03546 | Alternative IL-15 Tg (BALB) | Transgene | |
| RBRC03547 | IL-15 Tg (B6) | Transgene | |
| RBRC03548 | IL-15 Tg (BALB) | Transgene | |
| RBRC03572 | HCV Tg/#B6-2 | Transgene | |
| RBRC03573 | HCV Tg/#BD1 | Transgene | |
| RBRC03574 | HCV Tg/#BD30 | Transgene | |
| RBRC03575 | HCV Tg/#FA30 | Transgene | |
| RBRC03576 | HCV Tg/#FA44 | Transgene | |
| RBRC03577 | HCV Tg/#FA48 | Transgene | |
| RBRC03578 | HCV Tg/#FS2-5 | Transgene | |
| RBRC03579 | HCV Tg/#FS5 | Transgene | |
| RBRC03580 | MPA434 Tg/#34,35 | Transgene | |
| RBRC03581 | MPA434 Tg/#53 | Transgene | |
| RBRC03582 | MPA434 Tg/#56,59,60 | Transgene | |
| RBRC03583 | MPA434 Tg/#59 | Transgene | |
| RBRC03584 | MPA434 Tg/#60 | Transgene | |
| RBRC03585 | MPA434 Tg/#63,64,65 | Transgene | |
| RBRC03586 | MPA434 Tg/#64,65,66 | Transgene | |
| RBRC03587 | MPA434 Tg/#67 | Transgene | |
| RBRC03588 | MPA434 Tg/#68 | Transgene | |
| RBRC03589 | MPA434 Tg/#69 | Transgene | |
| RBRC03626 | B6.B6D2-Tg(EF1A-BCL2)1Ymat | Transgene | |
| RBRC03634 | CLZ Tg#34 | Transgene | |
| RBRC03705 | C57BL/6N-Tg(Nes-cre)52Utr/Rbrc | Transgene | Cre/loxP system FLP/frt system |
| RBRC03710 | C57BL/6Cr-Tg(Pcp2-HA/ATXN3*69Q)1Hirai | Transgene | Mouse Models for Human Disease Neurobiology Research |
| RBRC03711 | C57BL/6Cr-Tg(Pcp2-HA/rtTA)1Hirai | Transgene | Tet system |
| RBRC03737 | mG-5-L Tg | Transgene | Fluorescent Proteins/lacZ System |
| RBRC03738 | C57BL/6Cr-Tg(Pcp2-HA/rtTA)2Hirai | Transgene | Tet system |